Immunofluorescence staining indicated an elevation in the expression levels of calreticulin (CRT) and high-mobility group protein B1 (HMGB1) within tumor tissues following APPF+laser treatment, thereby promoting dendritic cells (DCs) maturation. The gene discussed is CALR; the disease is neoplasm.